Detalhe da pesquisa
1.
Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer.
Prostate
; 76(11): 977-85, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27062540
2.
Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis.
J Urol
; 195(6): 1690-6, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26678957
3.
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.
J Urol
; 195(4 Pt 1): 1120-5, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26454102
4.
Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study.
J Urol
; 194(4): 939-43, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25910967
5.
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09).
Oncology
; 89(2): 70-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25765871
6.
Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters.
World J Urol
; 33(10): 1541-52, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25433505
7.
Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
Int J Cancer
; 135(7): 1596-604, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615121
8.
Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05).
BJU Int
; 113(3): 429-36, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24053564
9.
Validation of a 3D-printed robot-assisted partial nephrectomy training model.
BJUI Compass
; 5(1): 90-100, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38179024
10.
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
Int J Cancer
; 130(12): 2922-9, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21815140
11.
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer.
BJU Int
; 110(6 Pt B): E308-17, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22500655
12.
Chronic Kidney Disease and Pregnancy. Guideline of the DGGG, OEGGG, DGfN (S2k Level, AWMF Registry No. 015â-â090).
Geburtshilfe Frauenheilkd
; 82(8): 795-830, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35967745
13.
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
Int J Cancer
; 128(6): 1486-92, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20473942
14.
Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.
BJU Int
; 107(7): 1069-73, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20825402
15.
Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tract.
Urol Int
; 86(1): 36-40, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21160157
16.
Inhibition of Rho-kinase abrogates migration of human transitional cell carcinoma cells: results of an in vitro study.
Urol Int
; 86(2): 220-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21051874
17.
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.
Cancer Sci
; 101(5): 1300-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20180812
18.
Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
Clin Cancer Res
; 14(24): 8253-62, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19088043
19.
Rap2B-dependent stimulation of phospholipase C-epsilon by epidermal growth factor receptor mediated by c-Src phosphorylation of RasGRP3.
Mol Cell Biol
; 24(11): 4664-76, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15143162
20.
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.
Int Urol Nephrol
; 48(3): 355-61, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26725072